| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |